Dongmun Ha

Suggest Changes
Learn More
RATIONALE, AIMS, AND OBJECTIVES Although nonpreference-based disease-specific measures are widely used in clinical studies, they cannot generate utilities for economic evaluation. A solution to this(More)
AIM The introduction of biosimilars is expected to reduce the cost of biologic drugs, but the actual cost savings have not yet been quantified in Korea. The aim of this study was to estimate the(More)
  • 1